The use of gene editing in gynecology raises several ethical questions:
1. Germline Editing: Editing the germline (sperm, eggs, or embryos) raises concerns because changes can be inherited by future generations. The long-term effects are unknown, leading to debates about the morality of such interventions.
2. Consent: For conditions treated at embryonic stages, obtaining informed consent is impossible. This raises questions about the autonomy and rights of the future individual.
3. Equity: Access to gene editing technologies may be limited to those who can afford them, potentially widening health disparities.
